ElMindA, the Israeli pioneer in neuroscience-based technology for analyzing brain network functionality, has announced an oversubscribed $28 million round of Series C financing. The proceeds will be used to continue advancement of ElMindA’s proprietary BNA (Brain Network Activation) system, which uses multi-channel EEG-ERP electrophysiology technology to provide a more accurate, objective...
Continue Reading >>










